SUBSCRIBE
SUBSCRIBE

Krystle Vermes

Drug Development
Scientists Look to Determine Why Some COVID-19 Patients Show Signs of Heart Damage
A study published in JAMA Cardiology back on July 27 is now raising concern in the medical community, as many coronavirus patients are exhibiting signs of heart damage, despite being asymptomatic.
August 18, 2020
 · 
2 min read
 · 
Krystle Vermes
Drug Development
Researchers Continue to Face Several Hurdles in COVID-19 Clinical Trials
Despite the urgent need for more research into the coronavirus, the New York Times reported on August 14 that there have been numerous testing delays, staffing shortages and space constraints tying up the process.
August 18, 2020
 · 
2 min read
 · 
Krystle Vermes
Gut Enzymes Show Promise in Helping to Identify Potential Diseases
According to a study published in Nature Communications on August 11, enzymes that are used by bacteria to break down mucus in the gut can potentially be useful biomarkers for intestinal diseases.
August 13, 2020
 · 
3 min read
 · 
Krystle Vermes
Drug Development
New Blood Test May Be Critical to Detecting Alzheimer’s Early in Patients
A study published in the Journal of the American Medical Association on July 29 now shows that a new blood test may be helpful for detecting Alzheimer’s disease as early as 20 years before the onset of cognitive impairment.
August 12, 2020
 · 
2 min read
 · 
Krystle Vermes
Drug Development
New Drug Discovery Process Could Significantly Cut Development Time
Simon Fraser University chemist Robert Britton and a team of international researchers believe that their findings could lead to a more efficient way of discovering drugs for newly evolved viruses as well, such as the SARS-CoV-2 (COVID-19).
August 11, 2020
 · 
2 min read
 · 
Krystle Vermes
Lone Star Bio
With $95M in New Funding, Taysha Gene Therapies Looks to Advance Pipeline
Texas-based Taysha Gene Therapies announced last week that it had concluded a Series B round of financing worth $95 million.
August 11, 2020
 · 
3 min read
 · 
Krystle Vermes
Programmed death ligand 1 is being said to be help
Business
Could Obesity Be Contributing to Severe Cases of COVID-19?
Although obesity is a known risk factor for death from many conditions, such as cardiovascular disease, experts are now wondering how COVID-19 may impact those who fall into this category.
August 6, 2020
 · 
2 min read
 · 
Krystle Vermes
Drug Development
Companies and Institutions Asked to Publicize Years Worth of Clinical Trial Data
According to a warning from federal officials last week, dozens of drug companies, universities and medical device manufacturers owe more than a decade’s worth of data from clinical trials.
August 5, 2020
 · 
2 min read
 · 
Krystle Vermes
Drug Development
New Research Sheds Light on the Temporary Loss of Smell Stemming from COVID-19
According to a study published in the journal Science Advances on July 24, an international team of researchers led by neuroscientists at Harvard Medical School has uncovered which olfactory cell types are most vulnerable to infection by SARS-CoV-2, which causes COVID-19.
August 4, 2020
 · 
3 min read
 · 
Krystle Vermes
Business
Sangamo and Novartis Enter Agreement to Focus on Neurodevelopmental Diseases
Genomic medicine company Sangamo Therapeutics announced today that it has entered a global licensing collaboration agreement with Novartis to develop and commercialize gene regulation therapies for three neurodevelopmental targets, including autism spectrum disorder.
July 30, 2020
 · 
3 min read
 · 
Krystle Vermes
New Study Shows How Aging Can Potentially Impact Lung Regeneration
A study published in the journal Cell Stem Cell today revealed how aging can cause lung regeneration to go awry, which can potentially lead to lung cancer and other diseases.
July 28, 2020
 · 
3 min read
 · 
Krystle Vermes
Drug Development
T Cells May Be Critical to Understanding Immunity to COVID-19
A number of studies have suggested that people infected with COVID-19 tend to have T cells that can target the virus. However, scientists are now also realizing that some people who can test negative for COVID-19 antibodies can test positive for T cells that identify the virus within the body.
July 27, 2020
 · 
2 min read
 · 
Krystle Vermes
New Pathways in RNA-based Viruses May Be Key to Boosting Drug Effectiveness
According to research from the University of New Hampshire (UNH), new pathways have been identified in an RNA-based virus where inhibitors can potentially unbind. This may be critical to understanding how inhibitors react within the body, and eventually lead to the development of more effective drugs.
July 24, 2020
 · 
2 min read
 · 
Krystle Vermes
Business
Elevation Oncology Launches with $32.5M in Series A Financing
In addition, the Phase II CRESTONE study has begun, examining the efficacy and safety of seribantumab in patients with solid tumors that feature a neuregulin-1 (NRG1) fusion.
July 21, 2020
 · 
3 min read
 · 
Krystle Vermes
Business
NovoCure, Merck Team Up on Phase II Lung Cancer Trial
Together, the companies will develop Tumor Treating Fields with Merck’s anti-PD-1 therapy, Keytruda for the treatment of non-small cell lung cancer (NSCLC).
July 15, 2020
 · 
3 min read
 · 
Krystle Vermes
Load More